Quaranta, V.N.; Portacci, A.; Montagnolo, F.; Dragonieri, S.; Iorillo, I.; Lulaj, E.; Maselli, L.; Buonamico, E.; Carpagnano, G.E.
Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study. J. Clin. Med. 2024, 13, 6309.
https://doi.org/10.3390/jcm13216309
AMA Style
Quaranta VN, Portacci A, Montagnolo F, Dragonieri S, Iorillo I, Lulaj E, Maselli L, Buonamico E, Carpagnano GE.
Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study. Journal of Clinical Medicine. 2024; 13(21):6309.
https://doi.org/10.3390/jcm13216309
Chicago/Turabian Style
Quaranta, Vitaliano Nicola, Andrea Portacci, Francesca Montagnolo, Silvano Dragonieri, Ilaria Iorillo, Ernesto Lulaj, Leonardo Maselli, Enrico Buonamico, and Giovanna Elisiana Carpagnano.
2024. "Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study" Journal of Clinical Medicine 13, no. 21: 6309.
https://doi.org/10.3390/jcm13216309
APA Style
Quaranta, V. N., Portacci, A., Montagnolo, F., Dragonieri, S., Iorillo, I., Lulaj, E., Maselli, L., Buonamico, E., & Carpagnano, G. E.
(2024). Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study. Journal of Clinical Medicine, 13(21), 6309.
https://doi.org/10.3390/jcm13216309
